DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Depocyt (Cytarabine) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Depocyt (Cytarabine) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (42)
Death (6)
Life Threatening Events (9)
Disability (6)

Reports by Reaction Type

Headache (9)Mucosal Inflammation (7)Arachnoiditis (6)Coma (6)Hepatic Enzyme Increased (6)Hyperkalaemia (5)Deafness (5)Pneumocystis Jiroveci Pneumonia (5)Herpes Simplex (5)Dysarthria (5)Pyrexia (4)Somnolence (4)

Below are a few examples of reports where side effects / adverse reactions may be related to Depocyt (Cytarabine). For a complete list or a specific selection of reports, please use the links above.

Possible Depocyt side effects in 21 year old female

Reported by a physician from United States on 2012-08-10

Patient: 21 year old female

Reactions: Aphasia, Hemiparesis, Leukoencephalopathy, Cerebrovascular Accident

Drug(s) suspected as cause:
Methotrexate
    Indication: Multiple Myeloma

Depocyt
    Dosage: inth
    Indication: Multiple Myeloma



Possible Depocyt side effects in

Reported by a physician from Slovakia (Slovak Republic) on 2012-08-10

Patient:

Reactions: CNS Ventriculitis

Drug(s) suspected as cause:
Depocyt



Possible Depocyt side effects in 63 year old female

Reported by a physician from France on 2012-07-18

Patient: 63 year old female

Reactions: Neurotoxicity, Subarachnoid Haemorrhage, Posterior Reversible Encephalopathy Syndrome, Encephalopathy, Coma, Leukoencephalopathy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depocyt
    Dosage: 40 mg, inth
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-07
    End date: 2012-05-24

Gleevec
    Dosage: 400 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-10
    End date: 2012-05-26

Methotrexate Sodium
    Dosage: 15 mg, inth
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-07
    End date: 2012-05-24

Other drugs received by patient: Gentamicin; Fluconazole; Vincristine; Amikacin; Heparin; Cyclophosphamide; Valacyclovir Hydrochloride; Pyostacine; Imipenem and Cilastatin Sodium; Vfend; Mesna; Flagyl; Vancomycin; Cotrim; Ciprofloxacin Hydrochloride; Amphotericin B; Vibramycin; Rocephin; Methylprednisolone; Idarubicin HCL; Aspegic 1000; Colimycin; Tazobactam; Zyvox



Possible Depocyt side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-13

Patient: female

Reactions: Ischaemic Stroke, Coma, Status Epilepticus, Aplasia, Convulsion, Subarachnoid Haemorrhage, Posterior Reversible Encephalopathy Syndrome, Sepsis, Oedema, Candidiasis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Imatinib Mesylate
    Dosage: 400 mg, daily
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-10
    End date: 2012-05-26

Depocyt
    Dosage: 40 mg, unk
    Start date: 2012-05-24

Depocyt
    Dosage: 40 mg, unk
    Start date: 2012-05-17

Methotrexate
    Dosage: 15 mg, unk
    Start date: 2012-05-17

Depocyt
    Dosage: 40 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-07

Methotrexate
    Dosage: 15 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-07

Methotrexate
    Dosage: 15 mg, unk
    Start date: 2012-05-24

Other drugs received by patient: Aspegic 1000; Bactrim DS; Tazobactam; Imipenem and Cilastatin Sodium; Fluconazole; Amikacin; Vincristine; Vibramycin D; Aspegic 1000; Fosphenytoin Sodium; Keppra; Vincristine; Gentamicin; Cyclophosphamide; Mesna; Colimycine; Pyostacine; Depakene; Iradubicin; Iradubicin; Fluconazole; Vincristine; Methylprednisolone; Ciprofloxacin Hydrochloride; Vancomycin; Mesna; Vfend; Iradubicin; Rocephin; Heparin Sodium; Flagyl; Amphotericin B; Zyvox; Clonazepam; Iradubicin; Valacyclovir Hydrochloride; Cyclophosphamide



Possible Depocyt side effects in 63 year old female

Reported by a physician from Austria on 2012-07-03

Patient: 63 year old female

Reactions: General Physical Health Deterioration, C-Reactive Protein Decreased, Asthenia, Hypokalaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Depocyt

Other drugs received by patient: Abraxane; Denosumab



Possible Depocyt side effects in 55 year old male

Reported by a physician from Belgium on 2012-06-21

Patient: 55 year old male

Reactions: Bone Marrow Failure, Toxicity To Various Agents, Aplasia, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Folic Acid
    Dosage: 200 mg;iv
    Indication: Metastases To Meninges
    Start date: 2009-07-03
    End date: 2009-07-05

Methylprednisolone
    Dosage: 100 mg;iv
    Indication: Metastases To Meninges
    Start date: 2009-07-02
    End date: 2009-07-05

Cyclophosphamide
    Dosage: 460 mg;iv
    Indication: Metastases To Meninges
    Start date: 2009-07-03
    End date: 2009-07-05

Rituximab (Rituximab)
    Dosage: 693 mg;iv
    Indication: Metastases To Meninges
    Start date: 2009-07-01
    End date: 2009-07-01

Methotrexate Sodium
    Dosage: 5500 mg;iv
    Indication: Metastases To Meninges
    Start date: 2009-07-02
    End date: 2009-07-02

Adriamycin PFS
    Dosage: 110 mg;iv
    Indication: Metastases To Meninges
    Start date: 2009-07-03
    End date: 2009-07-03

Vincristine
    Dosage: 2 mg;iv
    Indication: Metastases To Meninges
    Start date: 2009-07-02
    End date: 2009-07-02

Depocyt
    Dosage: 50 mg;inth
    Indication: Metastases To Meninges
    Start date: 2009-07-03
    End date: 2009-07-03



Possible Depocyt side effects in 63 year old female

Reported by a physician from Austria on 2012-06-21

Patient: 63 year old female

Reactions: General Physical Health Deterioration, C-Reactive Protein Decreased, Asthenia, Hypokalaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Depocyt

Other drugs received by patient: Denosumab; Abraxane



Possible Depocyt side effects in 14 year old male

Reported by a consumer/non-health professional from Norway on 2012-06-10

Patient: 14 year old male

Reactions: C-Reactive Protein, Listless, Arachnoiditis, Deafness, Pyrexia, Headache, Somnolence, Fall, Neurotoxicity, Fatigue, Chest Pain, Coordination Abnormal, Sinusitis, Decreased Appetite, Ataxia, Cognitive Disorder, Mucosal Inflammation, Medulloblastoma Recurrent, Dysarthria, Metastases To Spine, Visual Impairment, Hypothyroidism, Neutropenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Depocyt
    Dosage: initially given every other week,then monthly,cumulative dose 650mg,resatarted after 18months
    Indication: Medulloblastoma

Etoposide
    Dosage: 25 mg/day on alternate days; max 100mg daily (50 mg/m2 cumu dose:11.5 g/m2 over 31 months
    Administration route: Oral
    Indication: Medulloblastoma

Celecoxib
    Dosage: also taken 400mg bid 430mg/m2
    Administration route: Oral
    Indication: Medulloblastoma

Thalidomide
    Dosage: also taken 50mg 3mg/kg
    Administration route: Oral
    Indication: Medulloblastoma

Other drugs received by patient: Prednisolone Hydrogen Succinate; Dexamethasone



Possible Depocyt side effects in 63 year old female

Reported by a physician from Austria on 2012-06-08

Patient: 63 year old female

Reactions: General Physical Health Deterioration, Asthenia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Depocyt

Other drugs received by patient: Abraxane; Denosumab



Possible Depocyt side effects in male

Reported by a health professional (non-physician/pharmacist) from Norway on 2012-05-30

Patient: male, weighing 75.0 kg (165.0 pounds)

Reactions: Confusional State, Listless, Arachnoiditis, Deafness, Pyrexia, Headache, Somnolence, Fall, Fatigue, C-Reactive Protein Increased, Chest Pain, Sinusitis, Decreased Appetite, Ataxia, Hypoaesthesia, Paraesthesia, Haematotoxicity, Mucosal Inflammation, Dysarthria, Anxiety, Neutropenia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Etoposide
    Dosage: 25mg every other day for the last 8 months; cumulative dose of 11.5 g/m2 over 31 months
    Administration route: Oral

Thalidomide
    Dosage: maximal dose 200mg daily (3 mg/kg)
    Administration route: Oral
    Indication: Medulloblastoma Recurrent

Etoposide
    Dosage: maximal dose 100mg daily (50 mg/m2); cumulative dose of 11.5 g/m2 over 31 months
    Administration route: Oral
    Indication: Medulloblastoma Recurrent

Depocyt
    Dosage: 50mg on alternate weeks, gradually increased to every other month; 3-month break after 7th course
    Indication: Medulloblastoma Recurrent

Celecoxib
    Dosage: maximal dose 400mg x 2 daily (430 mg/m2)
    Administration route: Oral
    Indication: Medulloblastoma Recurrent

Other drugs received by patient: Prednisolone Sodium Succinate; Dexamethasone



Possible Depocyt side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-29

Patient: female

Reactions: Vomiting, Nausea, Dizziness, Headache

Drug(s) suspected as cause:
Depocyt

Other drugs received by patient: Dexamethasone



Possible Depocyt side effects in female

Reported by a physician from United States on 2012-05-29

Patient: female

Reactions: Back Pain

Drug(s) suspected as cause:
Depocyt



Possible Depocyt side effects in male

Reported by a health professional (non-physician/pharmacist) from Norway on 2012-04-26

Patient: male

Reactions: Dysarthria, Visual Impairment, Hypothyroidism, Ataxia, Deafness, Coordination Abnormal, Cognitive Disorder

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Temozolomide
    Dosage: not reported

(Therapeutic Radiopharmaceuticals)
    Dosage: 35 gy, unknown, other

Vincristine Sulfate
    Dosage: not reported

Etoposide
    Dosage: not reported

Cyclophosphamide
    Dosage: not reported

Carboplatin
    Dosage: 700 mg/m 2 milligram(s)/sq. meter

Cisplatin
    Dosage: 80 mg/m 2 milligram(s)/sq. meter

Depocyt
    Dosage: 50 mg milligram(s), intrathecal

(Lomustine)
    Dosage: not reported



Possible Depocyt side effects in 16 year old female

Reported by a physician from Spain on 2012-04-19

Patient: 16 year old female, weighing 56.0 kg (123.2 pounds)

Reactions: Pancytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 9 mg, 1x/day
    Start date: 2011-02-16
    End date: 2011-02-16

Depocyt
    Dosage: 35 mg, 1x/day
    Start date: 2011-02-16
    End date: 2011-02-16

Cytarabine
    Dosage: 3320 mg, 1x/day
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-02-12
    End date: 2011-02-13

Dexamethasone
    Dosage: 9 mg, 2x/day
    Administration route: Oral
    Start date: 2011-02-17
    End date: 2011-02-20

Vincristine Sulfate
    Dosage: 2 mg, 1x/day
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-02-08
    End date: 2011-02-08

Asparaginase
    Dosage: 1600 iu, 1x/day
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-02-13
    End date: 2011-02-13

Voriconazole
    Dosage: 360 mg, 2x/day
    Indication: Aspergillosis
    Start date: 2011-01-21
    End date: 2011-01-22

Voriconazole
    Dosage: 240 mg, 2x/day
    Start date: 2011-01-22
    End date: 2011-01-25

Dexamethasone
    Dosage: 11 mg, 3x/day
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-02-08
    End date: 2011-02-14

Other drugs received by patient: Polaramine; Fluconazole; Methotrexate; Leucovorin Calcium; Furosemide; Omeprazole; Acetaminophen; Septra; Emla; Pyridoxine; Toriol; Maxidex; Zofran



Possible Depocyt side effects in 65 year old male

Reported by a physician from United States on 2012-04-17

Patient: 65 year old male

Reactions: Encephalitis Cytomegalovirus, Graft Versus Host Disease, Central Nervous System Lesion, Panencephalitis, CNS Ventriculitis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Thiotepa
    Indication: Diffuse Large B-Cell Lymphoma

Thiotepa
    Indication: Myeloid Leukaemia

Thiotepa
    Indication: Myelodysplastic Syndrome

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Indication: Myeloid Leukaemia

Rituximab
    Indication: Myelodysplastic Syndrome

Idarubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma

Idarubicin HCL
    Indication: Myelodysplastic Syndrome

Idarubicin HCL
    Indication: Myeloid Leukaemia

Fludarabine Phosphate
    Indication: Diffuse Large B-Cell Lymphoma

Fludarabine Phosphate
    Indication: Myelodysplastic Syndrome

Fludarabine Phosphate
    Indication: Myeloid Leukaemia

Etoposide
    Indication: Diffuse Large B-Cell Lymphoma

Etoposide
    Indication: Myelodysplastic Syndrome

Etoposide
    Indication: Myeloid Leukaemia

Valaciclovir
    Indication: Myeloid Leukaemia

Valaciclovir
    Indication: Cytomegalovirus Infection

Valaciclovir
    Indication: Myelodysplastic Syndrome

Depocyt
    Indication: Diffuse Large B-Cell Lymphoma

Depocyt
    Indication: Myelodysplastic Syndrome

Depocyt
    Indication: Myeloid Leukaemia

Mitoxantrone
    Indication: Myelodysplastic Syndrome

Mitoxantrone
    Indication: Myeloid Leukaemia

Mitoxantrone
    Indication: Diffuse Large B-Cell Lymphoma

Anti-Thymocyte Globulin Equine NOS
    Indication: Diffuse Large B-Cell Lymphoma

Anti-Thymocyte Globulin Equine NOS
    Indication: Myelodysplastic Syndrome

Anti-Thymocyte Globulin Equine NOS
    Indication: Myeloid Leukaemia

Foscarnet
    Indication: Myelodysplastic Syndrome

Foscarnet
    Indication: Cytomegalovirus Infection

Foscarnet
    Indication: Myeloid Leukaemia

Acyclovir
    Indication: Myeloid Leukaemia

Acyclovir
    Indication: Cytomegalovirus Infection

Acyclovir
    Indication: Myelodysplastic Syndrome



Possible Depocyt side effects in 49 year old male

Reported by a physician from United Kingdom on 2012-04-11

Patient: 49 year old male

Reactions: Dyskinesia, Nuclear Magnetic Resonance Imaging Brain Abnormal, Headache

Drug(s) suspected as cause:
Depocyt

Other drugs received by patient: Acyclovir; Imatinib Mesylate; Fluconazole; Cotrim



Possible Depocyt side effects in 46 year old male

Reported by a physician from Norway on 2012-04-02

Patient: 46 year old male

Reactions: Neurotoxicity, Urinary Incontinence, Perineal Pain, Faecal Incontinence

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Depocyt

Other drugs received by patient: Rituximab; Sulfamethoxazole and Trimethoprim; Cyclophosphamide; Dexamethasone; Doxorubicin HCL; Dolcontin / 00036302 /; Zovirax / 00587301 /; Etoposide; Lactulose; Oxycodone HCL



Possible Depocyt side effects in 48 year old male

Reported by a physician from France on 2012-04-02

Patient: 48 year old male

Reactions: Agranulocytosis, Anaemia, Pain, Sepsis, Neoplasm Progression, Pyrexia, Headache, Thrombocytopenia, Prolymphocytic Leukaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ciprofloxacin
    Dosage: 500 mg;bid;iv
    Indication: Sepsis
    Start date: 2012-02-18
    End date: 2012-02-27

Depocyt
    Dosage: 50 mg;qow;inth
    Indication: Prolymphocytic Leukaemia
    Start date: 2012-01-14
    End date: 2012-01-31

Augmentin '125'
    Dosage: 1 gm;tid;iv
    Indication: Sepsis
    Start date: 2012-02-18
    End date: 2012-02-27

Other drugs received by patient: Coversyl / 00790702 /; Domperidone; Valacyclovir Hydrochloride; Adancor; Procoralan; Atenolol; Pantoprazole; Azathioprine; Atorvastatin; Clopidogrel Bisulfate and Aspirin; Bactrim; Gaviscon / 00237601 /



Possible Depocyt side effects in 21 year old male

Reported by a physician from Denmark on 2012-04-02

Patient: 21 year old male, weighing 120.0 kg (264.0 pounds)

Reactions: Arachnoiditis, Brain Oedema

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Depocyt

Other drugs received by patient: Tasigna



Possible Depocyt side effects in 20 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-02

Patient: 20 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Mucosal Inflammation, Herpes Simplex, Hyperkalaemia, Febrile Bone Marrow Aplasia, Hepatic Enzyme Increased

Drug(s) suspected as cause:
Doxorubicin HCL

Doxorubicin HCL

Dexamethasone

Depocyt
    Indication: Burkitt's Lymphoma

Dexamethasone

Cytarabine

Doxorubicin HCL
    Indication: Burkitt's Lymphoma

Vincristine

Methotrexate
    Indication: Burkitt's Lymphoma

Rituximab
    Dosage: day 1
    Indication: Burkitt's Lymphoma

Doxorubicin HCL

Doxorubicin HCL

Cyclophosphamide

Methotrexate

Cytarabine
    Indication: Burkitt's Lymphoma

Doxorubicin HCL

Doxorubicin HCL

Vincristine

Methotrexate

Prednisone TAB
    Indication: Burkitt's Lymphoma

Dexamethasone
    Indication: Burkitt's Lymphoma

Cytarabine

Cyclophosphamide
    Dosage: a1-a3

Cyclophosphamide

Vincristine
    Indication: Burkitt's Lymphoma

Vincristine

Doxorubicin HCL

Cyclophosphamide
    Indication: Burkitt's Lymphoma

Cyclophosphamide

Dexamethasone

Methotrexate

Cytarabine



Possible Depocyt side effects in male

Reported by a physician from Germany on 2012-03-15

Patient: male

Reactions: Bulbar Palsy, Mydriasis, Urinary Incontinence, Faecal Incontinence, Visual Acuity Reduced, General Physical Health Deterioration, Muscular Weakness, Respiratory Paralysis, Paraesthesia, Cranial Nerve Disorder, Eyelid Ptosis, Areflexia, Dysaesthesia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Depocyt
    Dosage: 50 mg;1x;inth
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-14
    End date: 2012-02-14

Depocyt
    Dosage: 50 mg;1x;inth
    Indication: Metastases To Meninges
    Start date: 2012-02-14
    End date: 2012-02-14

Other drugs received by patient: Aspirin; Pantoprazole; Avandia; Glimepiride; Dexamethasone; Methotrexate; Hydrochlorothiazide; Cytarabine; Ramipril



Possible Depocyt side effects in 63 year old female

Reported by a physician from Austria on 2012-03-15

Patient: 63 year old female, weighing 51.0 kg (112.2 pounds)

Reactions: Dysphagia, Dehydration, Hypophagia, Nervous System Disorder, Headache, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depocyt

Other drugs received by patient: Levothyroxine Sodium; Fortecortin / 00016001 /; Hydal; Elomel; Pantoloc / 01263201 /; Acecomb; Zofran; Vertirosan / 00019501 /; Bisoprolol Fumarate



Possible Depocyt side effects in 63 year old female

Reported by a physician from Germany on 2012-02-14

Patient: 63 year old female

Reactions: Visual Acuity Reduced, CSF Pressure Increased, Papilloedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depocyt

Other drugs received by patient: Oxazepam; Novalgin; Lyrica; Benalapril; Dexamethasone; Arimidex; Pantoprazole



Possible Depocyt side effects in 63 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-09

Patient: 63 year old female

Reactions: Death, Vomiting, Neoplasm Malignant, Nausea, Diarrhoea, Hepatic Enzyme Increased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Depocyt
    Dosage: 6sep11,20sep11
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-08-23
    End date: 2011-09-20

Sprycel
    Dosage: stoppd on 6sep10 and restartd on oct2011-death(13 month)
    Administration route: Oral
    Indication: Chronic Myeloid Leukaemia
    Start date: 2010-06-05



Possible Depocyt side effects in

Reported by a physician from Italy on 2012-01-25

Patient:

Reactions: Vision Blurred, Headache

Drug(s) suspected as cause:
Depocyt

Other drugs received by patient: Cyclophosphamide; Cytarabine; Etoposide; Dexamethasone; Vincristine; Doxorubicin HCL; Rituximab; Ifosfamide; Methotrexate



Possible Depocyt side effects in 58 year old male

Reported by a physician from Austria on 2012-01-17

Patient: 58 year old male, weighing 88.0 kg (193.6 pounds)

Reactions: Posturing, Vomiting, Restlessness, Body Temperature Increased, Aphasia, Coma, Hemiparesis, Disorientation, Disease Progression, Speech Disorder, Pleocytosis, Brain Oedema, Intracranial Pressure Increased, Hallucination, Altered State of Consciousness

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Depocyt

Other drugs received by patient: Pantoprazole Sodium; Novaban; Dulcolax; Dipidolor; Klysmol; Folsan; Lovenox; Structokabiven / 05981101 /; Diclobene; Myostatin; CAL D Vita; Hydromorphone HCL; Zantac; Scopolamine; Seractil



Possible Depocyt side effects in 58 year old male

Reported by a physician from Austria on 2012-01-06

Patient: 58 year old male, weighing 88.0 kg (193.6 pounds)

Reactions: General Physical Condition Abnormal, Arachnoiditis, Vomiting, Restlessness, Body Temperature Increased, Aphasia, Coma, Hemiparesis, Disorientation, Sopor, Speech Disorder, Apraxia, Pleocytosis, Hallucination, Altered State of Consciousness

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Depocyt

Other drugs received by patient: Dulcolax; Seractil; Lovenox; Zantac; Dislobene; Hydromorphone HCL; Mycostatin; Dipidolor; Navoban; Folsan; Structokabiven / 05981101 /; CAL D Vita; Pantoloc / 012632204 /; Klysmol; Scopolamine



Possible Depocyt side effects in male

Reported by a physician from Norway on 2011-12-28

Patient: male, weighing 75.0 kg (165.0 pounds)

Reactions: Confusional State, Arachnoiditis, Ataxia, Deafness, Pyrexia, Hypoaesthesia, Headache, Somnolence, Fall, Paraesthesia, Anxiety, Dysarthria, C-Reactive Protein Increased, Chest Pain, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depocyt

Other drugs received by patient: Dexamethasone; Thalidomide; Celecoxib; Prednisolone; Etoposide



Possible Depocyt side effects in 40 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2011-12-28

Patient: 40 year old female

Reactions: Pulmonary Embolism, Encephalopathy, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia Recurrent
    Start date: 2011-04-05
    End date: 2011-04-05

Idarubicin Hydrochloride
    Dosage: unk
    Start date: 2011-04-05
    End date: 2011-04-05

Depocyt
    Dosage: 50 mg, unk
    Indication: Acute Myeloid Leukaemia Recurrent
    Start date: 2011-04-05
    End date: 2011-04-05

Fludarabine Phosphate
    Dosage: unk
    Indication: Acute Myeloid Leukaemia Recurrent
    Start date: 2011-04-05
    End date: 2011-04-05

Other drugs received by patient: Neupogen



Possible Depocyt side effects in 20 year old male

Reported by a individual with unspecified qualification from Germany on 2011-12-16

Patient: 20 year old male

Reactions: Mucosal Inflammation, Pneumocystis Jiroveci Pneumonia, Hyperkalaemia, Herpes Simplex, Bone Marrow Failure, Hepatic Enzyme Increased

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 300 mg abs. in a1-a3

Cyclophosphamide
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Indication: Burkitt's Lymphoma

Depocyt
    Indication: Burkitt's Lymphoma

Vincristine
    Indication: Burkitt's Lymphoma

Dexamethasone
    Indication: Burkitt's Lymphoma

Rituximab
    Indication: Burkitt's Lymphoma

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017